Directed homing of SIV-specific TCR-engineered T cells to B-cell follicles through ectopic expression of CXCR5

被引：0
|
作者：
Burke, J. Daniel [1 ]
Deleage, C. [1 ]
Trivett, M. T. [1 ]
Coren, L. V. [1 ]
Hill, B. J. [1 ]
Ayala, V. I. [1 ]
Breed, M. W. [1 ]
Kramer, J. A. [1 ]
Del Prete, G. Q. [1 ]
Swanstrom, A. [1 ]
Lifson, J. [1 ]
Ott, D. E. [1 ]
机构：
[1] Leidos Biomedical Res Inc, Frederick Natl Lab Canc Res, AIDS & Canc Virus Program, Frederick, MD USA
来源：
JOURNAL OF MEDICAL PRIMATOLOGY | 2020年 / 49卷 / 05期
关键词：
D O I：
暂无
中图分类号：
S85 [动物医学（兽医学）];
学科分类号：
0906 ;
摘要：
33
引用
收藏
页码：238 / 238
页数：1
相关论文
共 13 条
  • [1] SIV-specific CD8 T cells are largely excluded from B cell follicles during early SIV infection
    Li, Shengbin
    Connick, Elizabeth
    Skinner, Pamela J.
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [2] The human IL-15 superagonist ALT-803 directs SIV-specific CD8+ T cells into B-cell follicles
    Webb, Gabriela M.
    Li, Shengbin
    Mwakalundwa, Gwantwa
    Folkvord, Joy M.
    Greene, Justin M.
    Reed, Jason S.
    Stanton, Jeffery J.
    Legasse, Alfred W.
    Hobbs, Theodore
    Martin, Lauren D.
    Park, Byung S.
    Whitney, James B.
    Jeng, Emily K.
    Wong, Hing C.
    Nixon, Douglas F.
    Jones, R. Brad
    Connick, Elizabeth
    Skinner, Pamela J.
    Sacha, Jonah B.
    BLOOD ADVANCES, 2018, 2 (02) : 76 - 84
  • [3] The human IL-15 superagonist ALT-803 activates NK and memory T cells, reactivates latent SIV and drives SIV-specific CD8+T cells into B-cell follicles
    Webb, G.
    Li, S.
    Greene, J.
    Reed, J.
    Stanton, J.
    Legasse, A.
    Park, B.
    Axthelm, M.
    Jeng, E.
    Wong, H.
    Whitney, J.
    Jones, B.
    Nixon, D.
    Skinner, P.
    Sacha, J.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2017, 20 : 80 - 80
  • [4] Balanced expression of CXCR5 and CCR7 on follicular T helper cells determines their transient positioning to lymph node follicles and is essential for efficient B-cell help
    Hardtke, S
    Ohl, L
    Förster, R
    BLOOD, 2005, 106 (06) : 1924 - 1931
  • [5] Hypermethylation at the CXCR5 gene locus limits trafficking potential of CD8+T cells into B-cell follicles during HIV-1 infection
    Ogunshola, Funsho J.
    Smidt, Werner
    Naidoo, Anneta F.
    Nkosi, Thandeka
    Ngubane, Thandekile
    Khaba, Trevor
    Baiyegunhi, Omolara O.
    Mahlobo, Bongiwe
    Rasehlo, Sam
    Ngema, Namani
    Jajbhay, Ismail
    Dong, Krista L.
    Ramsuran, Veron
    Pansegrouw, Johan
    Ndung'u, Thumbi
    Walker, Bruce D.
    de Oliveria, Tulio
    Ndhlovu, Zaza M.
    BLOOD ADVANCES, 2022, 6 (06) : 1904 - 1916
  • [6] CXCR5-Dependent Entry of CD8 T Cells into Rhesus Macaque B-Cell Follicles Achieved through T-Cell Engineering
    Ayala, Victor I.
    Deleage, Claire
    Trivett, Matthew T.
    Jain, Sumiti
    Coren, Lori V.
    Breed, Matthew W.
    Kramer, Joshua A.
    Thomas, James A.
    Estes, Jacob D.
    Lifson, Jeffrey D.
    Ott, David E.
    JOURNAL OF VIROLOGY, 2017, 91 (11)
  • [7] The human IL-15 superagonist complex ALT-803 activates NK and memory T cells, reactivates latent SIV, and drives SIV-specific CD8+ T cells into B cell follicles
    Webb, Gabriela
    Hammond, Katherine
    Li, Shengbin
    Mwakalundwa, Gwantwa
    Greene, Justin
    Reed, Jason
    Stanton, Jeffrey
    Legasse, Alfred
    Park, Byung
    Axthelm, Michael
    Jeng, Emily
    Wong, Hing
    Whitney, James
    Jones, Brad
    Nixon, Douglas
    Skinner, Pamela
    Sacha, Jonah
    JOURNAL OF MEDICAL PRIMATOLOGY, 2018, 47 (05) : 307 - 307
  • [8] Balanced expression of CXCR5 and CCR7 on follicular T helper cells determines their transient positioning to lymph node follicles and is essential for efficient B cell help
    不详
    IMMUNOBIOLOGY, 2004, 209 (4-6) : 310 - 310
  • [9] Expression and Clinical Significance of CXCR5 and LAG-3 on Peripheral Blood CD8+ T Cells in Patients With Diffuse Large B-Cell Lymphoma
    Guo, Xi-Zhe
    Guo, Ya-Fei
    Wu, Shi-Xin
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2025,
  • [10] Phase I Clinical Trial of CD19 CAR-T Cells Expressing CXCR5 Protein for the Treatment of Relapsed or Refractory B-cell Lymphoma
    Wang, Jiaxi
    Jiang, Yirong
    Luo, Min
    Lu, Wenyi
    He, Jixiang
    Zhang, Meng
    Yao, Zhuoxin
    Jin, Xin
    Xiao, Xia
    Chen, Jianhang
    Li, Guangchao
    Ding, Wen
    Zhou, Jie
    Zhang, Zhiyin
    Zhao, Mingfeng
    CURRENT CANCER DRUG TARGETS, 2024,
12